|
Real-time
Euronext Paris
06:02:09 2026-11-05 am EST
|
5-day change | 1st Jan Change | ||
| 19.75 EUR | +3.67% |
|
+5.61% | -34.82% |
| Sep. 17 | Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Apr. 22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 331M 371M 303M 276M 518M 35.08B 530M 3.63B 1.45B 18.57B 1.39B 1.36B 58.81B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 283M 317M 259M 236M 443M 30B 453M 3.1B 1.24B 15.88B 1.19B 1.17B 50.3B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
12.84% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| BOI | Real-time | |
CBOE
| BOIp | Real-time | |
Börse Stuttgart
| BON | Delayed | |
Deutsche Boerse AG
| BON | Delayed | |
CBOE
| 0DTF | Real-time | |
Boerse Muenchen
| BON | Real-time |
| 1 day | +3.67% | ||
| 1 week | +5.61% | ||
| Current month | +5.61% | ||
| 1 month | +3.95% | ||
| 3 months | -28.18% | ||
| 6 months | -27.12% | ||
| Current year | -34.82% |
| 1 week | 18.5 | 19.75 | |
| 1 month | 16.9 | 19.75 | |
| Current year | 16.9 | 30.95 | |
| 1 year | 16.9 | 32.25 | |
| 3 years | 16.9 | 43.96 | |
| 5 years | 16.9 | 56.5 | |
| 10 years | 16.9 | 92.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 2024-12-31 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 2011-06-30 |
| Director/Board Member | 54 | 2010-03-09 | |
| Director/Board Member | 51 | 2013-05-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/29/23 | Sell | Director | 198,664 | 1.1323% | ||
| 10/29/23 | Sell | Director | 462,964 | 2.6387% | ||
| 10/29/23 | Sell | Director | 4,748 | 0.0271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.67% | +5.61% | -29.21% | -51.35% | 371M | ||
| +0.61% | +10.07% | +56.36% | +149.73% | 1,263B | ||
| +3.81% | +1.95% | +47.88% | +82.58% | 665B | ||
| +3.09% | +3.09% | +36.56% | +108.48% | 521B | ||
| -0.37% | -1.72% | +48.92% | +66.48% | 387B | ||
| +3.93% | +6.69% | +79.30% | +45.44% | 371B | ||
| -0.36% | +1.27% | +31.90% | +59.05% | 310B | ||
| +0.11% | +7.59% | +12.79% | +36.65% | 293B | ||
| +3.73% | +5.90% | +61.27% | +77.31% | 259B | ||
| +4.19% | +9.60% | +41.85% | +113.85% | 216B | ||
| Average | +1.77% | +5.33% | +38.76% | +68.82% | 428.58B | |
| Weighted average by Cap. | +1.33% | +5.96% | +48.76% | +97.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 547M 447M 406M 764M 51.71B 781M 5.34B 2.14B 27.37B 2.05B 2.01B 86.7B | 501M 562M 460M 418M 785M 53.14B 803M 5.49B 2.2B 28.13B 2.11B 2.07B 89.11B |
| Net income | 11.34M 12.72M 10.4M 9.45M 17.76M 1.2B 18.17M 124M 49.81M 636M 47.75M 46.73M 2.02B | 32.64M 36.63M 29.94M 27.2M 51.14M 3.46B 52.31M 358M 143M 1.83B 137M 135M 5.8B |
| Net Debt | -49.74M -55.82M -45.61M -41.45M -77.93M -5.27B -79.71M -545M -219M -2.79B -210M -205M -8.84B | -47.86M -53.7M -43.89M -39.88M -74.98M -5.08B -76.69M -525M -210M -2.69B -202M -197M -8.51B |
Employees
2,623
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-05 | €19.75 | +3.67% | 1,361 |
| 26-11-04 | €19.05 | +1.33% | 4,740 |
| 26-11-03 | €18.80 | -1.05% | 1,679 |
| 26-11-02 | €19.00 | +1.60% | 3,777 |
| 26-10-30 | €18.70 | 0.00% | 1,878 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
Select your edition
All financial news and data tailored to specific country editions

















